STOCK TITAN
  1. Home
  2. Sec-filings
  3. MEDP
  4. [Form 4] Medpace Holdings, Inc. Insider Trading Activity

Medpace (NASDAQ: MEDP) director converts restricted stock units into common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Medpace Holdings director Cornelius P. McCarthy III exercised restricted stock units into common shares. He acquired 28 shares of Medpace common stock through the conversion of restricted stock units, bringing his direct common stock holdings to 10,352 shares. Following this transaction, he continues to hold 56 restricted stock units that each represent a contingent right to receive one share of Medpace common stock upon future vesting.

Positive

  • None.

Negative

  • None.
Insider McCarthy Cornelius P. III
Role null
Type Security Shares Price Value
Exercise Restricted Stock Unit 28 $0.00 --
Exercise Common Stock 28 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 56 shares (Direct, null); Common Stock — 10,352 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
Common shares acquired 28 shares Common Stock acquired via RSU exercise on June 30, 2026
Common shares held after 10,352 shares Direct Medpace common stock holdings following transaction
RSUs converted 28 restricted stock units Derivative transaction converting RSUs into common stock
RSUs remaining 56 restricted stock units Outstanding RSUs after June 30, 2026 transaction
Original RSU grant 113 restricted stock units Granted November 28, 2025, vesting in four installments in 2026
Restricted Stock Unit financial
"The filing reports transactions in a security titled "Restricted Stock Unit" linked to common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
derivative security financial
"Transaction code M is described as "Exercise or conversion of derivative security.""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of MEDP common stock."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McCarthy Cornelius P. III
(Last)(First)(Middle)
C/O MEDPACE HOLDINGS, INC.
5375 MEDPACE WAY
(Street)
CINCINNATI OHIO 45227
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026M28A(1)10,352D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)06/30/2026M28 (2) (2)Common Stock28$056D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
2. On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
Remarks:
/s/ Stephen P. Ewald, Attorney-in-Fact for Cornelius P. McCarthy III07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Medpace (MEDP) director Cornelius P. McCarthy III report?

Director Cornelius P. McCarthy III exercised restricted stock units into Medpace common shares. He acquired 28 common shares through a derivative exercise, increasing his direct common stock holdings while retaining additional unvested restricted stock units.

How many Medpace (MEDP) common shares does Cornelius P. McCarthy III hold after this Form 4?

After the reported transaction, Cornelius P. McCarthy III directly holds 10,352 shares of Medpace common stock. This figure reflects his position following the exercise of 28 restricted stock units into common shares on June 30, 2026.

What happened to the restricted stock units in the Medpace (MEDP) Form 4 filing?

The filing shows 28 restricted stock units converted into 28 Medpace common shares. After this derivative exercise, 56 restricted stock units remain outstanding, each representing a contingent right to receive one share of Medpace common stock upon vesting.

Was the Medpace (MEDP) insider transaction a market purchase or sale?

The transaction was not an open-market buy or sell. It was an exercise of restricted stock units into common stock, reported with transaction code M, which denotes the exercise or conversion of a derivative security rather than a market trade.

What do the Medpace (MEDP) restricted stock unit footnotes explain in this Form 4?

The footnotes explain that each restricted stock unit represents a contingent right to receive one Medpace common share. They also state that 113 restricted stock units were granted on November 28, 2025, vesting in four approximately equal installments during 2026.